Zobrazeno 1 - 10
of 309
pro vyhledávání: '"Xiaohong Xie"'
Autor:
Ni Sun, Ru Li, Haiyi Deng, Qingyang Li, Jiaxi Deng, Yue Zhu, Wenwei Mo, Wenhui Guan, Minjuan Hu, Ming Liu, Xiaohong Xie, Xinqing Lin, Chengzhi Zhou
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveTo compare the prognostic differences between non-small cell lung cancer (NSCLC) patients with mild and severe checkpoint inhibitor-associated pneumonitis (CIP), and explore the causes of death and prognostic risk factors in NSCLC patients w
Externí odkaz:
https://doaj.org/article/a0acd3267d57404ea2ed28cc5e6e1e9e
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Atypical Chronic Myeloid Leukemia (aCML), a myeloproliferative neoplasm with poor prognosis, was reclassified as aCML by the ICC classification, and as MDS/MPN with neutrophilia by the WHO 2022 classification. Due to the heterogeneity of its clinical
Externí odkaz:
https://doaj.org/article/070feebc8b0b4daea31834f68fcfa96e
Autor:
Xiaohong Xie, Wenhui Guan, Wenting Huang, Juhong Jiang, Haiyi Deng, Yijia Li, Huixin Jiang, Ming Liu, Chengzhi Zhou
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24373- (2024)
A Chinese male patient with advanced lung adenocarcinoma experienced disease progression one and a half years after receiving first-line immunochemotherapy. The second biopsy was performed and tissue immunohistochemistry revealed Anaplastic lymphoma
Externí odkaz:
https://doaj.org/article/d1248b8b3b3444eea947a16f9c95d7b8
Autor:
Guihuan Qiu, Fei Wang, Xiaohong Xie, Ting Liu, Chen Zeng, Ziyao Chen, Maolin Zhou, Haiyi Deng, Yilin Yang, Xinqing Lin, Zhanhong Xie, Gengyun Sun, Chengzhi Zhou, Ming Liu
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 14881-14891 (2023)
Abstract Background The treatment of extensive stage small‐cell lung cancer (ES‐SCLC) has only made modest progress in the past decade, with two immune checkpoint inhibitors (ICIs), atezolizumab and durvalumab, approved for the treatment of SCLC
Externí odkaz:
https://doaj.org/article/7f927dc7876b44539095cd23ecd983c6
Autor:
Xue Wang, Jingjing Yu, Xiaodong Fan, Suya Ma, Xiaohong Xie, Ning Gao, Shuaishuai Huang, Aimei Lu
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Alveolar soft part sarcoma (ASPS) is a rare kind of malignant soft tissue tumor with undefined differentiation, of which the incidence rate accounts for only 0.5–1.0% among all kinds of soft tissue tumors. An even rarer ASPS occ
Externí odkaz:
https://doaj.org/article/ffcf63a45c6a47a797e765409ef4caec
Autor:
Guoxia Yang, Yi Qin, Yonghong Jia, Xiaohong Xie, Dongbin Li, Baoxin Jiang, Qu Wang, Siyu Feng, Yueyan Wu
Publikováno v:
BMC Plant Biology, Vol 23, Iss 1, Pp 1-23 (2023)
Abstract Background To reveal the key genes involved in the phenylpropanoid pathway, which ultimately governs the fragrance of Rhododendron fortunei, we performed a comprehensive transcriptome and metabolomic analysis of the petals of two different v
Externí odkaz:
https://doaj.org/article/d05bf1e2c2f5476ba187e9de43e84e1f
Autor:
Xiaohong Xie, Maolin Zhou, Liqiang Wang, Fei Wang, Haiyi Deng, Yiling Yang, Ni Sun, Ru Li, Ying Chen, Xinqing Lin, Ming Liu, Chengzhi Zhou
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
This study aimed to evaluate the efficacy of combining immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in treating lung cancer patients with bone metastases (BMs), as it is unclear whether this combination is effective for this conditi
Externí odkaz:
https://doaj.org/article/b59450cc29d3473ebacc433ef3d5751c
Autor:
Lesang Shen, Jun Zhou, Yiding Chen, Jinhua Ding, Haiyan Wei, Jian Liu, Wenjie Xia, Bojian Xie, Xiaohong Xie, Xujun Li, Yuechu Dai, Guobing Zhang, Xia Qiu, Chao Li, Shanshan Sun, Wuzhen Chen, Dihe Gong, Hengyu Li, Jian Huang, Xia Jiang, Chao Ni
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4157-4168 (2022)
Abstract Background Palbociclib was the only available cyclin‐dependent kinase 4/6 inhibitor in China until very recently, and its effect has not been systemically evaluated among Chinese patients. This study aims to assess the efficacy, safety and
Externí odkaz:
https://doaj.org/article/27faaebab4924b45b61f73902142f23a
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract Background Sirtuins (SIRTs) have key roles in cancer progression. However, the prognostic implications of SIRTs in breast cancer (BC) remains a subject of debate and controversy. Thus, we performed a meta-analysis to identify the precise pro
Externí odkaz:
https://doaj.org/article/eae4b1c2ffd744c9bdf257fffeb8b873
Autor:
Xiaohong Xie, Jianhui Wu, Bingpeng Guo, Liqiang Wang, Haiyi Deng, Xinqing Lin, Ming Liu, Yinyin Qin, Wei Luo, Yilin Yang, Xiao Zou, Ting Hou, Jianxing Xiang, Zhange Chen, Chengzhi Zhou
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Sputum biopsies offer unique advantages such as non-invasiveness and convenient collection. The one investigation so far on sputum for genome profiling in advanced non-small cell lung cancer (aNSCLC) suggested promising performanc
Externí odkaz:
https://doaj.org/article/9b19335ac23749ccb9f2132705800e8f